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Abstract
A comment on Semple JI, Vavouri T, Lehner B. A simple principle concerning the robustness of
protein complex activity to changes in gene expression. BMC Syst Biol. 2008;2:1
Effects of gene under-expression
I have read with interest the paper by Semple et al. (2008)
dealing with the phenotypic effects of protein under- and
overexpression as a function of their belonging to protein
complexes [1]. Semple et al. 2008 confirmed that, in yeast,
genes that inhibit growth when underexpressed often
encode subunits of protein complexes. This finding was
valid for both core and peripheral subunits. They also
reanalyzed overexpression data from an array of yeast
strains each one overexpressing a single gene. This array
covered 85% of all yeast genes [2]. Semple et al. (2008)
find that genes leading to growth defects when over-
expressed are not enriched amongst the core or peripheral
subunits of protein complexes [1]. Accordingly, they pro-
pose a simple principle: "the overall activity of a protein
complex is in general robust to an increase, but not to a
decrease in the expression of its subunits". The verifica-
tion of such a simple principle would be more than wel-
come: at least something simple in biology. With this
note, I merely seek to point out places where existing
incomplete data leaves untested some hypotheses. Thus,
the comment that follows is not a rebuttal of Semple's
work.
The first point that attracts the attention in the paper by
Semple et al. is the fact that complete gene deletions
(when dealing with essential genes or those whose
absence leads to a growth defect) are taken as underex-
pression and not as plain absence of expression. This can
be considered as a matter of words but only 'haploinsuffi-
cient genes' should qualify as truly underexpressed in
their analysis.
In the context of macromolecular complexes an alteration
of the stoichiometric balance (i.e. relative amounts)
between/among the subunits has been suggested, and
often experimentally confirmed, to be harmful and to
lead to fitness defects. These alterations result from under-
expression (i.e. haploinsufficiency) or overexpression (i.e.
in the case of trisomy) of a subunit [3,4]. The proposal of
the existence of stoichiometric rules governing the assem-
bly of complexes has been coined as the gene dosage "bal-
ance hypothesis" (DBH) [5]. The idea of balance is natural
in itself, in the context of complexes, and is also naturally
extensible to signaling and transcriptional networks
where there are often clearly opposed actors (i.e. a protein
kinase "versus" a phosphatase [6]). However, to compli-
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cate matters, a complex is most often not isolated but
embedded within a cellular (sub)network. Thus, the
impact of altering the dosage balance between the subu-
nits can be buffered or, on the contrary, amplified by the
relevant network in which the complex in embedded.
Predicting a priori the phenotypic effect of gene underex-
pression is a difficult task. However, there are cases where
strong effects can be expected without taking big risks. For
example, if a complex involves identical subunits linked
to a common partner (as A in A-B-A) and assembly fol-
lows a random pathway (i.e. AB and BA are allowed), a
decrease in the concentration of A can lead to a dramatic
and non-proportional reduction of trimer yield (<<50%
with respect to the wild-type level [3,4]). Even if the com-
plex is embedded in a robust network, such an important
decrease of active [A-B-A] might be difficult to buffer.
However, halving the amount of subunits present only
one time within the complex is expected to lead, in gen-
eral, to a proportional decrease in the concentration of
complex (i.e. a 50% loss). In such cases the effects of
underexpression are much less predictable. However, it is
clear from the analysis performed by Semple et al. that
buffering gene underexpression does not work for a signif-
icant proportion of genes encoding subunits of com-
plexes. Unfortunately, whether these subunits tend to be
present in multiple copies within the complex or not
remains to be explored.
The physicochemical conjecture of the effects of gene
underexpression exposed in the context of the trimer A-B-
A can be extended to conserved paralogs in the yeast
genome (i.e. when their products are functionally inter-
changeable) [[7] and references therein]. In such
instances, the analysis of Semple et al. on essential genes
or genes whose deletions induce a growth defect becomes
relevant.
A (statistical) lack of effect of gene over-
expression?
The problem experienced by ABA when A is underex-
pressed can be also figured out as resulting from the rela-
tive excess of B. Accordingly, when B is overexpressed in
the presence of a normal amount of A there will also be a
decrease of ABA (excess of B leads to inactive subcom-
plexes A-B and B-A). This is also valid for any other com-
plex where B is a bridge between separable subunits or
subcomplexes [3,4,8].
In their preliminary analysis (Fig. 1), Semple et al. find
that genes leading to fitness defects when overexpressed
do not encode subunits of protein complexes more often
than expected by random. However, they should recall
that the DBH does not predict that overexpression of any
type of subunit will lead to a fitness defect. At least as pub-
lished, the DBH does predict that overexpression of a
molecular bridge between two subunits/subcomplexes, in
a clearly specified set of conditions, are more likely to
decrease the yield of trimer/multimer [3,4,8]. This might
also be the case in less straightforward situations such as
when there are secondary contacts between the subunits/
subcomplexes (such as A-A interactions in ABA, which is
now 'triangular' and not linear, see ref. 8). Of course, over-
expression of a subunit can be toxic in itself not because
the stoichiometry of the complex has been altered but
because the monomer contains a domain whose function
is autonomous (enzymatic or DNA/RNA binding) and
whose excess simply interferes with some metabolic proc-
ess.
In agreement with the predictions of the DBH, it has been
reported that gene pairs encoding interacting subunits
tend to have the same number of paralogs (with respect to
random expectation), and that genes belonging to huge
families rarely encode subunits of complexes [5,9]. These
findings can be taken as evidence that overexpression of
genes whose products are involved in complexes (and
almost certainly in signaling and transcriptional net-
works) does provoke a disadvantage at an evolutionary
scale, whose trace is the selective removal of paralogs of
genes involved in complexes or, on the contrary, their co-
retention after a whole-genome duplication.
Semple et al. analyze the effects of gene essentiality, hap-
loinsufficiency, overexpression on growth in more details.
Specifically, they explore whether genes leading to under-
or overexpression phenotypes cluster within complexes.
For this, they create bins representing the proportion of
subunits in the relevant complexes whose altered expres-
sion leads to a phenotype. Concerning their expected dis-
tributions, it would be interesting to understand why they
are so different according to the types of genes they con-
sider (i.e. essential, haploinsufficient, etc) and why
according to the bins under consideration, real protein
complexes are overrepresented or underrepresented with
respect to random expectation.
From previous discussions it is clear that the types of subu-
nits expected to produce under- and overexpression pheno-
types are quite different. Thus, the potential clustering of
dosage-sensitive (DS) subunits should depend on the topol-
ogy (linear, triangular, or other types of spatial arrange-
ments) and the stoichiometry of the complexes analyzed. In
short, clustering of DS subunits when underexpressed are
more likely to happen in complexes containing several sub-
units present (in the simplest case) in multiple copies per
complex. Clustering of DS subunits when overexpressed is
expected for instance in complexes where there are multiple
bridges such as in A-B-C-D-E (where B, C and D can be DS).
These expected outcomes are just a matter of possibility notBMC Systems Biology 2009, 3:16 http://www.biomedcentral.com/1752-0509/3/16
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of probability (as far as the kinetic and thermodynamic
details of the assembly are unknown).
Beyond this theoretical discussion there is a reported clus-
tering of haploinsufficient subunits, which deserves expla-
nation. It is possible that yeast simply needs more than
50% of protein complex to properly work (i.e. low robust-
ness). Thus, halving the amount of any monomer leads to
a growth phenotype. Alternatively, and not exclusively,
clustering of DS subunits when underexpressed might
also be due to a frequent presence of 'repeated' subunits
in complexes (i.e. such as A in A-B-A). This may be linked
to the fact that the distribution of protein-protein interac-
tions in yeast follows approximately power law [10]. In
short, most subunits are poorly connected while only a
small number have many partners. This general trend
should be valid for protein complexes as well. Thus, most
subunits will have, say, 2, 3, 4 protein-protein contacts.
Proteins known to establish 2 or 3 contacts can be
repeated subunits within the same complex. This is worth
being tested by taking into account curated protein-pro-
tein interaction data.
Before closing this section it is interesting to explore the
limits of the statistical analysis of clustering in the partic-
ular case of overexpressed subunits. Let us concentrate on,
say, trimers of the type A-B-A or A-B-C. We will assume
that, in ALL cases, overexpression of the molecular bridge
leads to a fitness defect. This is by far not random and is
also predicted by a physicochemical reasoning. Then we
assign the values 0 for 'no growth defect' and 1 for 'growth
defect' when the subunits are overexpressed. Two thirds of
the subunits will be of type 0 (i.e. the 'non-bridge' subu-
nits) and only one third will be 1 (i.e. the bridges). Thus,
100% of our trimers will be in bin 0.33. Indeed, a higher
degree of clustering of DS subunits in such trimers is NOT
predicted by the DBH. To prepare an expected set, we cre-
ate random trimers and allow all possible arrangements
(000, 010, 100, 111, etc). This random distribution tells
that bin 0 contains 29% of random trimers, bin 0.33 con-
tains 44%, 22% will belong to bin 0.66 and the rest to bin
1. What should we conclude from a statistical comparison
between the observed and expected distributions? Since
71% of random trimers belong to bin 0.33 or higher do
we just 'save' 29% of our trimers (i.e. not expected to occur
at random). Given that only bin 0.33 is relevant for our
trimers, according to the DBH, do we save 66% of them?
Depending on our choice we would conclude that, for
trimers, overexpression of a bridge is either a rather minor
or a major factor leading to a phenotype when there is
overexpression of a subunit.
An acid test for the DBH
An acid test for the prediction that overexpression can be
harmful will be the systematic analysis of the effects of over-
expression of, for instance, molecular bridges within the
complexes. This criterion is a good startpoint and can/should
be relaxed to other subunits that establish links between sub-
complexes even if the latter have secondary contacts (see
models in ref. 8). This kind of analysis seems to be difficult
today because neither the stoichiometry nor the topology are
known for a wide variety of complexes. However, this infor-
mation will be accessible in the future, when crystallographic
data for complexes will be available, which will make the
aforementioned prediction easily falsifiable. Structural data
would only be a first step of the acid test because the simple
condition of being a bridge is not really enough. The kinetics
of assembly can also play a role (see [6] and especially its
supplemental material). For instance, if assembly is ordered/
sequential (i.e. first AB, then ABC) overexpression of B has
no effect. But even if the kinetics data is not available, the
analysis of structural data will drive us closer to the truth. We
can make some explorations while waiting. Previous works
have shown the existence of high mRNA iso-expression (i.e.
similar number of mRNA molecules) for proteins involved
in the same complex [5,11,12]. However, there are subunits
that are more 'isoexpressed' than others. The concentrations
of the former are more likely to be in fine balance. Thus, if
one takes mRNA level as a proxy of protein level, one way to
go further is to concentrate the analyses on subunits display-
ing the highest degree of iso-expressivity.
Some examples of fitness defects linked to gene 
overexpression
Next I would like to mention several heuristic examples of
well-characterized (and not very especially chosen) com-
plexes where overexpression of a subunit is harmful. It
should be noted that in several instances the phenotypes
are subtler than plain absence of growth.
The yeast genes GPA1, STE4, and STE18 encoding the
homologs of the mammalian G-protein α, β, and γ subunits,
respectively [13,14] form a linear heterotrimer of the ABC-
type (where β is a bridge). This trimer is essential for the
transduction of the mating pheromone signal in haploid
cells (for the pheromones, the transducer is the dimer βγ
itself). As predicted, overexpression of the bridge STE4 alone
triggers a response typical of pheromone signal transduction
[13]. Of course, co-overexpression of STE4 and STE18 trig-
gers the response as well. These results can be explained by a
disruption of the heterotrimer with a concomitant genera-
tion of free βγ dimers. Not surprisingly, overexpression of
STE18 alone has none of these effects because STE4 is limit-
ing [13]. Since GPA1 is also a promiscuous bridge between
the rest of the trimer and membrane receptors, its overex-
pression leads to diminished signaling due to sequestration
of free βγ and probably of the G-coupled receptor that senses
the stimulus [15].
The Snf1/AMP-activated protein kinase, involved in stress
response such as glucose limitation, provides another
example. The Snf1 trimer contains the α catalytic Snf1 sub-
unit, one of three β subunits (Gal83, Sip1 or Sip2) which
are bridges and the γ subunit Snf4. Overexpression of theBMC Systems Biology 2009, 3:16 http://www.biomedcentral.com/1752-0509/3/16
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bridge Sip2, decreases the activation of Snf1, not only by
disrupting the trimer but also by potentially altering the
subcellular localisation of the catalytic Snf1 subunit [16].
We can also explore the complex Sir2/3/4. Sir2 is an NAD-
dependent deacetylase involved in chromatin silencing and
in telomere position effect in yeast. Silencing is mediated
by the Sir heterotrimer, which involves the catalytic subunit
Sir2 and the structural proteins Sir3 and Sir4. Recombinant
Sir2, Sir3, and Sir4 have been shown to interact with each
other directly (with affinities yet to be determined) which
leads to a triangular complex [17]. Interestingly, overex-
pression of Sir4 interferes with silencing and leads to a well-
known "anti-SIR" effect [18]. The negative effect of Sir4 on
silencing is compensated for by co-overexpression of Sir3
[18]. Upon overexpression of Sir2, Sir3 or Sir4, only
increasing Sir3 copy number enhances the telomeric posi-
tion effect, which suggests that Sir3 is a limiting component
of the holo-SIR complex [19]. Overexpression of Sir2
results in a lifespan extension of about 30% (lifespan = the
number of cell divisions underwent by the cell before
dying) [20]. Thus, the anti-Sir effect of Sir4 overexpression
is expected to somehow reduce yeast lifespan (in a way that
might escape high-throughput screening?).
Mlc1 is an essential gene that exhibits haploinsufficiency
[21]. It interacts with the neck of the essential myosin
Myo2 through six IQ motifs of the latter. The complex
Myo2/Mlc1 participates in intracellular transport and the
structure of the complex Mlc1p-IQ has been solved [22].
Haploinsufficiency of Mlc1 might be explained by the fact
that several molecules of Mlc1 are expected to recognize
the multiple IQ motifs of Myo2 (which is a dimer itself,
[23]). Thus, halving the amount of Mlc1 very likely leads
to a dramatic decrease in active Myo2/Mlc complex
(<<<50%)! Indeed for multimers such as AnB (where sev-
eral A monomers interact only with B and n>2), the non-
linear effects of either halving A or increasing B sharpen as
n increases [8]. Not surprisingly, overexpression of Myo2
is toxic and causes a severe growth defect, which is com-
pensated by overexpressing Mlc1 [21]. The effect of Myo2
overexpression has two alternative and not mutually
exclusive explanations. Since each Myo2 molecule plays a
role as a bridge by providing 6 IQ sequences for Mlc1, its
overexpression will lead to a decreased amount of active
complexes through insufficient occupancy of the IQ sites.
Moreover, since Myo2 is not the only target of Mlc1 (i.e.
Mlc1 also binds to a class II myosin [24]) it may also play
a transdominant negative role (i.e. Myo2 titrates Mlc1
molecules required by other myosins) [25].
A transdominant negative effect can also arise when the
monomers 'A' can form homo- and heterodimers (i.e. AA
and AB) or when they are shared by several partners (i.e.
AB, AC, AD, etc). Overexpression of one of the partners
will affect the relative concentrations of all dimers. A text-
book example is provided by the transcription factors
Oaf1 and Pip2. They mediate the induction of genes
encoding peroxisomal proteins involved in fatty acid
metabolism when oleate is present in the growth medium
[26]. Oaf1 may form homodimers that induce the expres-
sion of some, but not all oleate-responsive genes, which
are fully induced by Oaf1-Pip2 heterodimers [27]. This
suggests that Oaf1p alone, most likely in the form of a
homodimer, may be recruited to the promoter of a subset
of target genes and that the heterodimer may help recog-
nize a larger subset of targets [28]. As expected, overex-
pression of Oaf1 inhibits fatty acid metabolism by
shifting the balance homo-/heterodimer [29].
Interestingly, out of the genes mentioned above, whose
overexpression is known to produce a phenotype only
STE4/YOR212W appeared in the data used by Semple et
al. Just for the sake of the argument, it would be interest-
ing to know how their conclusions would change (or not)
if they had access to phenotypic information of the 15%
of genes that Sopko et al. did not test.
If protein complexes in yeast cells are pervasively robust to
gene overexpression (at least concerning growth and
related phenotypes) the challenge will be to move from a
'principle' of robustness to something more mechanistic.
On general grounds Semple et al. have proposed some
possibilities leading to robustness when a protein subunit
is overexpressed. These and other possibilities have also
been examined in ref. 30. As a matter of example we can
consider how sequential protein binding during complex
formation may help avoid dosage effects [4,30]. At least
large complexes, such as the ribosome, are assembled in a
'factory line' fashion. A few subunits interact first, some
post-translational modifications take place, then more
subunits are added to the growing complex, along with
more processing, and so on. Accordingly, binding of pro-
teins to the bacterial 16 S rRNA occurs hierarchically,
which suggests that early binding proteins organize the
binding sites for subsequent proteins. This has been stud-
ied in detail for the interactions of proteins S7, S9, S10,
and S3, for which binding of one protein strongly
enhances recruitment of a subsequent one ([31]and refer-
ences therein). A similar strategy is expected to be used in
the assembly of the eukaryote ribosome. Is this a general
rule, which might explain Semple's finding, or a specifi-
city of huge complexes? This remains to be studied.
All in all, Semple et al. did the best they could. Thus, I sim-
ply suggest that their results are open to re-interpretation
in the future as more experimental data become available.
The mechanisms of phenotypic change in response to
increased gene expression
Jennifer I Semple, Tanya Vavouri and Ben LehnerBMC Systems Biology 2009, 3:16 http://www.biomedcentral.com/1752-0509/3/16
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Whilst it is likely that overexpressing certain specific sub-
units of certain protein complexes disrupts their assembly
and function, global analyses in yeast demonstrate that
this cannot be a common explanation for toxicity in
response to increased gene expression [32-34]. This does
not mean that the mechanism is not important, merely
that other, more widespread mechanisms must exist that
cause toxicity when genes are overexpressed. It is also clear
from the global data in yeast that most subunits of most
protein complexes can be overexpressed with no observa-
ble phenotypic consequence under laboratory conditions
[32-34]. This is still true when considering protein com-
plexes that are performing an essential function in these
conditions, and for those where reducing the expression
of most subunits is lethal [33]. Where analyzed, overex-
pression phenotypes are normally different to the loss-of-
function phenotypes that result from inhibition of the
same genes [34]. Elucidating the molecular mechanisms
that cause these gain-of-function phenotypes remains an
important challenge for many areas of biology.
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